Neogenomics, Inc.
NEO
$7.42
$0.294.07%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -25.92M | -15.32M | -17.70M | -18.64M | -27.06M |
| Total Depreciation and Amortization | 17.73M | 18.19M | 17.99M | 18.11M | 18.27M |
| Total Amortization of Deferred Charges | 735.00K | 732.00K | 730.00K | 727.00K | 725.00K |
| Total Other Non-Cash Items | 12.38M | 10.27M | 10.74M | 11.64M | 10.26M |
| Change in Net Operating Assets | -30.24M | -4.07M | -2.51M | 2.06M | -28.11M |
| Cash from Operations | -25.33M | 9.80M | 9.25M | 13.89M | -25.92M |
| Capital Expenditure | -4.50M | -11.60M | -10.80M | -13.08M | -5.59M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 8.06M | 6.13M | 7.28M | 20.39M | 20.11M |
| Cash from Investing | 3.56M | -5.47M | -3.52M | 7.31M | 14.53M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 949.00K | 3.54M | 1.18M | 1.97M | 816.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -2.86M | -- | -- | -- |
| Cash from Financing | 949.00K | 687.00K | 1.18M | 1.97M | 816.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -20.82M | 5.02M | 6.91M | 23.17M | -10.57M |